Current management of patients hospitalized with community-acquired pneumonia across Europe: Outcomes from REACH

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Blasi, Francesco ^a   Garau, Javier ^b   Medina, Jesús ^c   Ávila, Marco ^c   McBride, Kyle ^d   Ostermann, Helmut ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c ASTRAZENECA   (United Kingdom)

^d Instat Consulting Inc   (United States)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antibacterial agents; Clinical management; Community acquired pneumonia; Retrospective studies

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BELGIUM; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; FEMALE; FRANCE; GERMANY; GREECE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ITALY; LENGTH OF STAY; MALE; MEDICAL HISTORY; MORTALITY; MULTICENTER STUDY; NETHERLANDS; OBSERVATIONAL STUDY; PORTUGAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPAIN; TURKEY (REPUBLIC); UNITED KINGDOM; ADOLESCENT; COMMUNITY-ACQUIRED INFECTIONS; EUROPE; HOSPITALIZATION; MIDDLE AGED; PNEUMONIA; TREATMENT OUTCOME; YOUNG ADULT;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; EUROPE; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876112426     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-44     Document Type: Article

References (32)

1. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002, 36:20s-27s.
2. Welte T. Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. Eur J Clin Microbiol Infect Dis 2012, 31:33-47. 10.1007/s10096-011-1272-4, 21533875.
3. Welte T, Kohnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med 2009, 30:127-135. 10.1055/s-0029-1202941, 19296412.
4. Capelastegui A, Espana PP, Bilbao A, Gamazo J, Medel F, Salgado J, Gorostiaga I, Esteban C, Altube L, Gorordo I, Quintana JM. Study of community-acquired pneumonia: incidence, patterns of care, and outcomes in primary and hospital care. J Infect 2010, 61:364-371. 10.1016/j.jinf.2010.07.015, 20692290.
5. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect 2011, 17(Suppl 6):E1-E59.
6. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72.
7. Martinez R, Reyes S, Lorenzo MJ, Menendez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 2009, 30:172-178. 10.1055/s-0029-1202936, 19296417.
8. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001, 56(Suppl 4):IV1-IV64. 1765992, 11713364.
9. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2010, 67:71-79.
10. Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother 2008, 9:229-241. 10.1517/14656566.9.2.229, 18201146.
11. Bauer TT, Welte T, Ernen C, Schlosser BM, Thate-Waschke I, de Zeeuw J, Schultze-Werninghaus G. Cost analyses of community-acquired pneumonia from the hospital perspective. Chest 2005, 128:2238-2246. 10.1378/chest.128.4.2238, 16236880.
12. World Health Organization International Classification of Diseases (ICD) 10th Revision (2007 version) 2007, Geneva, Switzerland: World Health Organization, World Health Organization.
13. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250. 10.1056/NEJM199701233360402, 8995086.
14. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382. 10.1136/thorax.58.5.377, 1746657, 12728155.
15. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, Singer DE. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998, 279:1452-1457. 10.1001/jama.279.18.1452, 9600479.
16. Ramirez JA, Anzueto AR. Changing needs of community-acquired pneumonia. J Antimicrob Chemother 2011, 66(Suppl 3):iii3-iii9. 3143426, 21482567.
17. Garau J, Baquero F, Perez-Trallero E, Perez JL, Martin-Sanchez AM, Garcia-Rey C, Martin-Herrero JE, Dal-Ré R. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008, 14:322-329. 10.1111/j.1469-0691.2007.01915.x, 18190569.
18. Blasi F, Iori I, Bulfoni A, Corrao S, Costantino S, Legnani D. Can CAP guideline adherence improve patient outcome in internal medicine departments?. Eur Respir J 2008, 32:902-910. 10.1183/09031936.00092607, 18508826.
19. Garcia-Vidal C, Carratala J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med 2009, 30:154-160. 10.1055/s-0029-1202934, 19296415.
20. Stralin K, Olcen P, Tornqvist E, Holmberg H. Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores. Scand J Infect Dis 2010, 42:426-434. 10.3109/00365540903552353, 20141490.
21. Garcia-Vidal C, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, Gudiol F. Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 2009, 15:1033-1038. 10.1111/j.1469-0691.2009.02918.x, 19673961.
22. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009, 103:309-316. 10.1016/j.rmed.2008.08.006, 18804355.
23. Gutierrez F, Masia M, Rodriguez JC, Mirete C, Soldan B, Padilla S, Hernandez I, De Ory F, Royo G, Hidalgo AM. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect 2005, 11:788-800. 10.1111/j.1469-0691.2005.01226.x, 16153252.
24. Hedlund J, Ortqvist A, Ahlqvist T, Augustinsson A, Beckman H, Blanck C, Burman LA, Claesson B, Qvarfordt I, Elbel E, Erntell M, Follin P, Goscinski G, Holmberg H, Hofer M, Jorup C, Lidman C, Lindhusen E, Rensfeldt G, Rosenkvist E, Stenlund G, Stalberg A, Verngren K, Vig I, Wendahl S. Management of patients with community-acquired pneumonia treated in hospital in Sweden. Scand J Infect Dis 2002, 34:887-892. 10.1080/0036554021000026965, 12587620.
25. Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agusti C, Angrill J, Garcia E, Mensa J, Niederman MS, Torres A. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007, 132:515-522. 10.1378/chest.07-0306, 17505026.
26. Tudose C, Bumbacea D, Bogdan M. Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study. Pneumologia 2011, 60:30-35.
27. Valles X, Marcos A, Pinart M, Piner R, Marco F, Mensa JM, Torres A. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?. Chest 2006, 130:800-806. 10.1378/chest.130.3.800, 16963678.
28. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754. 10.1164/ajrccm.163.7.at1010, 11401897.
29. Dambrava PG, Torres A, Valles X, Mensa J, Marcos MA, Penarroja G, Camps M, Estruch R, Sanchez M, Menendez R, Niederman MS. Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J 2008, 32:892-901. 10.1183/09031936.00163407, 18550608.
30. Orrick JJ, Segal R, Johns TE, Russell W, Wang F, Yin DD. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines. Pharmacoeconomics 2004, 22:751-757. 10.2165/00019053-200422110-00005, 15250752.
31. Merchant S, Mullins CD, Shih YC. Factors associated with hospitalization costs for patients with community-acquired pneumonia. Clin Ther 2003, 25:593-610. 10.1016/S0149-2918(03)80099-1, 12749516.
32. Brown PD. Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?. Pharmacoeconomics 2004, 22:413-420. 10.2165/00019053-200422070-00001, 15137880.